BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 25, 2013
View Archived Issues
Abbott, Janssen and Pharmacyclics collaborate on companion test for leukemia therapy
Read More
KineMed, Isis Pharmaceuticals and CHDI Foundation form biomarker collaboration
Read More
NIH-funded trial of Shigella vaccine candidates to commence
Read More
New ACC1 inhibitors disclosed by Bayer Intellectual Property
Read More
University of Colorado and Orphan Technologies expand collaboration
Read More
FDA grants priority review to Epigenomics' PMA for Epi proColon
Read More
Zeria announces the Japanese launch of agent for hypophosphatemia
Read More
BioMarin licenses factor VIII gene therapy program for hemophilia A
Read More
Novel MPGES-1 inhibitors show promising anti-inflammatory properties
Read More
Novo Nordisk plans launch of Tresiba in Japan
Read More
Novel PAF receptor antagonists demonstrate neuroprotective properties
Read More
Abbott Laboratories synthesizes novel GlyT-1 inhibitors
Read More
Daiichi Sankyo discloses new hypoglycemic agents
Read More
Novel MAb shows potency as plasma kallikrein inhibitor
Read More
Novel RORgamma modulators patented by Tempero Pharmaceuticals
Read More
Biota Scientific Management presents new antiviral agents
Read More
Meda to begin phase II flupirtine trial in fibromyalgia
Read More
Pentraxin-related protein PTX3 levels are associated with carotid plaque vulnerability
Read More
EMA confirms decision on VIVUS' MAA for obesity treatment
Read More
Trastuzumab emtansine obtains first approval
Read More
NINDS funds tumor cell proliferation research at The Scripps Research Institute
Read More
Novartis terminates OX-17 program agreement with Orexo
Read More
NR2 peptide plasma assay as a new diagnostic tool for acute cerebrovascular events
Read More
Taxol approved for new indication in Japan
Read More
Phase III trial of cilengitide in glioblastoma fails to meet primary endpoint
Read More
Ablynx and Spirogen form anticancer drug conjugate collaboration
Read More